Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Long-Term Debt Issuances
Ratios

Opus Genetics (IRD) Accumulated Depreciation & Amortization (2021 - 2024)

Opus Genetics (IRD) has disclosed Accumulated Depreciation & Amortization for 5 consecutive years, with $21000.0 as the latest value for Q2 2023.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 23.53% to $21000.0 in Q2 2023 year-over-year; TTM through Jun 2023 was $21000.0, a 23.53% increase, with the full-year FY2022 number at $19000.0, up 26.67% from a year prior.
  • Accumulated Depreciation & Amortization was $21000.0 for Q2 2023 at Opus Genetics, up from $20000.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $21000.0 in Q2 2023 to a low of $14000.0 in Q3 2021.
  • A 3-year average of $17666.7 and a median of $18000.0 in 2022 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: rose 26.67% in 2022, then increased 23.53% in 2023.
  • Opus Genetics' Accumulated Depreciation & Amortization stood at $15000.0 in 2021, then increased by 26.67% to $19000.0 in 2022, then increased by 10.53% to $21000.0 in 2023.
  • Per Business Quant, the three most recent readings for IRD's Accumulated Depreciation & Amortization are $21000.0 (Q2 2023), $20000.0 (Q1 2023), and $19000.0 (Q4 2022).